The entry of new players and new approaches into the ATTR-CM space could help bring down the cost of treatment, experts say.

The U.S. Food and Drug Administration is poised to sign off as soon as this week on updated COVID-19 vaccines that target ...

Inside the arena, Democrats will amplify their campaign messaging of positivity over “weird” and help highlight Vice ...

Thousands of Native Americans elders stand to reap the benefits of lowered prescription drugs thanks to a new deal worked out ...

Thousands are seeking compensation for harm allegedly caused by coronavirus vaccines, according to the paper Almost 14,000 ...

The US Food and Drug Administration is poised to sign off as soon as next week on updated Covid-19 vaccines targeting more ...

Novo Nordisk reports robust GLP-1, obesity, and diabetic therapy market shares in the North American and International ...

Bristol Myers Squibb ( BMY 0.51%) has had a rough past five years. Its shares are barely in the green, its financial results ...

Pfizer was the envy of the pharmaceutical world, with more than $100 billion in annual sales from its COVID-19 vaccine and antiviral Paxlovid.

Drugstores remain an important fixture of the U.S. health-care system that tens of millions of Americans rely on, but they ...

Over half of Fortune 500 companies cite AI as a risk in 2023. Learn about the concerns and opportunities of AI adoption ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.